About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.


Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.


We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Current Vacancies

Scroll for more

Latest News

Check out what is happening at HCD Economics

August 2019

Making a difference and giving Huntington’s Disease patients and their families a real voice

Cath Stanley, Chief Executive of The Huntington’s Disease Association (HDA), speaks to Hayley from the HCD Huntington’s Disease study team about wanting to make a difference for patients and families affected by Huntington’s Disease and how the HDA partnership with HCD and University of Chester on the forthcoming Real World Evidence (Burden of Illness) study will work in practice and how the evidence drawn from the study will be a part of making that difference.
Continue Reading
July 2019

New Patient and Public Involvement (PPI) research paper confirms the relevance of data linkage analysis that involves PPI

An article published in the June 2019 edition of the Journal 'Research Involvement and Engagement' reports the findings from work undertaken by the Maudsley Biomedical Research Centre (BRC). The article describes the experience of the authors (Amelia Jewell et al) in setting up a service user and carer advisory group with the aim of providing feedback and advice to researchers developing or making use of database linkages in the field of mental health research. After a trial period of 12 months, the team conducted an evaluation of the group with both group members and presenters.
Continue Reading
Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more


Here are a few of the comments made by partners and clients about our collaborations

"The team at HCD Economics are ‘creative, responsive, knowledgeable, expert, agile, conscientious and reliable!’"

Burden of illness pharmaceutical industry partner


"I’ve worked with HCD Economics on a range of projects with excellent results including literature reviews, real world evidence generation and analyses, validation of outcomes measures, and designing outcomes studies. The team are very knowledgeable, very responsive to communications and always engaged in understanding the project requirements and the wider strategic requirements. I would not hesitate in recommending HCD Economics."

Shire plc


"At the British Liver Trust, we have been alarmed at the sharp increase in the number of people being diagnosed with NASH (non-alcoholic steatohepatitis) in the UK. They are often relatively young people in the prime of their lives and the diagnosis often comes as a complete shock. There has been scant research into the impact of NASH on patients’ quality of life, and on the direct and indirect costs of NASH to individuals and society. That is why the British Liver Trust welcomes the GAIN (Global Assessment of the Impact of NASH) study and is pleased to be involved in the research with HCD Economics."

Judi Rhys, CEO at BLT (British Liver Trust)

Scroll for more